1. Wu G, Xu Y, Schultz R, Chen H, Xie J, Deng M, Liu X, Gui X, John S, Lu Z, Arase H, Zhang N, An Z, Zhang CC. (2021) LILRB3 supports acute myeloid leukemia development and regulates T cell anti-tumor immune responses through the TRAF2-cFLIP-NF-kB signaling axis. Nat Cancer. 2:1170-84.
2. Gu Z, Liu Y, Zhang Y, Cao H, Lyu J, Wang X, Wylie A, Newkirk S, Jones A, Lee M, Botten G, Deng M, Dickerson K, Zhang CC, An W, Abrams J, Xu J. (2021) Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia. Nat Genet. 53(5):672-82.
3. Anami Y, Deng M, Gui X, Yamaguchi A, Yamazaki C, Zhang N, Zhang CC, An Z, and Tsuchikama K. (2020) LILRB4-Targeting Antibody–Drug Conjugates for the Treatment of Acute Myeloid Leukemia. Mol Cancer Ther. 19:2330-2339.
4. Li Z, Deng M, Huang F, Jin C, Sun S, Chen H, Liu X, He L, Sadek AH, Zhang CC. (2020) LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells. Cell Mol Immunol. 17(3):272-282.
5. Gui X, Deng M, Song H, Chen Y, Xie J, Li Z, He L, Huang F, Xu Y, Anami Y, Yu H, Yu C, Li L, Yuan Z, Xu X, Wang Q, Chai Y, Huang T, Shi Y, Tsuchikama K, Liao XC, Xia N, Gao GF, Zhang N, Zhang CC, An Z. (2019) Disrupting LILRB4/APOE interaction by an efficacious humanized antibody reverses T cell suppression and blocks AML development. Cancer Immunol Res. 7(8):1244-57.
6. Deng M, Gui X, Kim J*, Xie L, Chen W, Li Z, He L, Chen Y, Chen H, Luo W, Lu Z, Xie J, Churchill H, Xu Y, Zhou Z, Wu G, Yu C, John S, Hirayasu K, Nguyen N, Liu X, Huang F, Li L, Deng H, Tang H, Sadek AH, Zhang L, Huang T, Zou Y, Chen B, Zhu H, Arase H, Xia N, Jiang Y, Collins R, You MJ, Homsi J, Unni N, Lewis C, Chen G-Q, Fu Y-X, Liao XC, An Z, Zheng J, Zhang N, Zhang CC. (2018) LILRB4 signalling in leukaemia cells mediates T cell suppression and tumor infiltration. Nature. 562(7728):605-9.
7. John S, Chen H, Deng M, Gui X, Wu G, Chen W, Li Z, Zhang N, An Z, Zhang CC. (2018) A novel anti-LILRB4 CAR-T cell for the treatment of monocytic AML. Mol Ther. 26(10):2487-95.
8. Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, Han X, Xie F, Tyner JW, Coligan JE, Collins RH, Xiao X, You MJ, Zhang CC. (2015) The ITIM-containing receptor LAIR1 is essential for acute myeloid leukemia development. Nat Cell Biol. 17(5):665-77.
9. Deng M, Lu Z, Zheng J, Wan X, Chen X, Hirayasu K, Sun H, Lam Y, Chen L, Wang Q, Song C, Huang N, Gao GF, Jiang Y, Arase H, Zhang CC. (2014) A motif in LILRB2 critical for ANGPTL2 binding and activation. Blood. 124(6):924-35.
10. Yu X, Wang Y, Deng M, Li Y, Ruhn KA, Zhang CC, Hooper LV. (2014) The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife. 3. doi: 10.7554/eLife.04406.